Erik I. Tucker

3.1k total citations
77 papers, 2.4k citations indexed

About

Erik I. Tucker is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Erik I. Tucker has authored 77 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Hematology, 57 papers in Genetics and 14 papers in Immunology. Recurrent topics in Erik I. Tucker's work include Blood Coagulation and Thrombosis Mechanisms (64 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (56 papers) and Platelet Disorders and Treatments (15 papers). Erik I. Tucker is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (64 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (56 papers) and Platelet Disorders and Treatments (15 papers). Erik I. Tucker collaborates with scholars based in United States, Russia and Netherlands. Erik I. Tucker's co-authors include András Gruber, David Gailani, Owen J. T. McCarty, Anton Matafonov, Cristina Puy, Stephen R. Hanson, Qiufang Cheng, Sawan Hurst, Mao-fu Sun and Christina U. Lorentz and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Erik I. Tucker

69 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik I. Tucker United States	28	1.6k	1.5k	477	432	399	77	2.4k
Cristina Puy United States	21	812 0.5×	708 0.5×	220 0.5×	316 0.7×	195 0.5×	51	1.3k
Katrin F. Nickel Germany	14	669 0.4×	771 0.5×	244 0.5×	238 0.6×	163 0.4×	16	1.3k
Evi X. Stavrou United States	23	560 0.3×	631 0.4×	176 0.4×	293 0.7×	151 0.4×	44	1.4k
Cheryl F. Scott United States	24	1.1k 0.7×	1.6k 1.1×	373 0.8×	404 0.9×	100 0.3×	38	2.3k
Mirella Ezban Denmark	36	2.8k 1.7×	817 0.5×	52 0.1×	176 0.4×	359 0.9×	129	3.6k
Andy T. Long Germany	10	347 0.2×	412 0.3×	131 0.3×	483 1.1×	68 0.2×	10	1.1k
Richard J. Travers United States	13	428 0.3×	287 0.2×	64 0.1×	307 0.7×	158 0.4×	20	1.2k
Zafer Gülbaş Türkiye	24	1.2k 0.8×	240 0.2×	56 0.1×	426 1.0×	84 0.2×	142	2.1k
J.J. Emeis Netherlands	21	1.1k 0.7×	151 0.1×	133 0.3×	308 0.7×	218 0.5×	51	2.4k
G D Wilner United States	21	1.1k 0.7×	325 0.2×	61 0.1×	208 0.5×	346 0.9×	36	2.3k

Countries citing papers authored by Erik I. Tucker

Since Specialization

Citations

This map shows the geographic impact of Erik I. Tucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik I. Tucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik I. Tucker more than expected).

Fields of papers citing papers by Erik I. Tucker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik I. Tucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik I. Tucker. The network helps show where Erik I. Tucker may publish in the future.

Co-authorship network of co-authors of Erik I. Tucker

This figure shows the co-authorship network connecting the top 25 collaborators of Erik I. Tucker. A scholar is included among the top collaborators of Erik I. Tucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik I. Tucker. Erik I. Tucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Puy, Cristina, Jiaqing Pang, Christina U. Lorentz, et al.. (2024). Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo. Blood. 144(17). 1821–1833. 11 indexed citations

Puy, Cristina, Ravi S. Keshari, Robert Silasi‐Mansat, et al.. (2024). The physicochemical properties of lipopolysaccharide chemotypes regulate activation of the contact pathway of blood coagulation. Journal of Biological Chemistry. 301(1). 108110–108110. 4 indexed citations

Liang, Yideng, Qijin Lu, A. M. Shibeko, et al.. (2023). Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation. Blood Advances. 7(11). 2622–2631.

Healy, Laura D., Erik I. Tucker, David Gailani, et al.. (2023). Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice. Metabolic Brain Disease. 38(7). 2383–2391. 6 indexed citations

Verbout, Norah G., Weiping Su, Kelley R. Jordan, et al.. (2023). Cytoprotective E-WE thrombin reduces disease severity in a murine model of relapsing-remitting multiple sclerosis. American Journal of Physiology-Cell Physiology. 326(1). C40–C49.

Fallon, Marie, Luke M. Healy, Christina U. Lorentz, et al.. (2023). OC 49.2 Pharmacological Targeting of the Contact Pathway Attenuates Experimental Autoimmune Encephalomyelitis in Mice. Research and Practice in Thrombosis and Haemostasis. 7. 100482–100482. 1 indexed citations

Cao, Yang, John H. Griffin, David Gailani, et al.. (2023). PB0592 Evaluation of the Role of Skeletal Muscle Myosin as a Cofactor for Factor XI Activation of Factor XII. Research and Practice in Thrombosis and Haemostasis. 7. 100789–100789. 1 indexed citations

Wallisch, Michael, Yasser Khder, Jennifer Johnson, et al.. (2023). OC 62.4 Factor XI(a) Antibody Abelacimab Reduces Thrombus Growth andPropagation in a Baboon Model of Vascular Graft Thrombosis. Research and Practice in Thrombosis and Haemostasis. 7. 100318–100318.

Jordan, Kelley R., Cory Wyatt, Randy Woltjer, et al.. (2022). Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis. Journal of Thrombosis and Haemostasis. 20(9). 2035–2045. 14 indexed citations

10.

Silasi‐Mansat, Robert, Ravi S. Keshari, Cristina Lupu, et al.. (2021). Factor XII plays a pathogenic role in organ failure and death in baboons challenged withStaphylococcus aureus. Blood. 138(2). 178–189. 19 indexed citations

11.

Lorentz, Christina U., Erik I. Tucker, Norah G. Verbout, et al.. (2021). The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial. Blood. 138(22). 2173–2184. 89 indexed citations

12.

Wallisch, Michael, Sven R. Olson, Jeffrey R. Crosby, et al.. (2020). Evaluation of the Antihemostatic and Antithrombotic Effects of Lowering Coagulation Factor VII Levels in a Non-human Primate. Cellular and Molecular Bioengineering. 13(3). 179–187. 2 indexed citations

13.

Lorentz, Christina U., Jennifer Johnson, Cristina Puy, et al.. (2020). Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis. Cellular and Molecular Bioengineering. 14(2). 161–175. 15 indexed citations

14.

Tucker, Erik I., Norah G. Verbout, Brandon D. Markway, et al.. (2020). The protein C activator AB002 rapidly interrupts thrombus development in baboons. Blood. 135(9). 689–699. 7 indexed citations

15.

Wallisch, Michael, Christina U. Lorentz, Jennifer Johnson, et al.. (2020). Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates. Research and Practice in Thrombosis and Haemostasis. 4(2). 205–216. 41 indexed citations

16.

Shirai, Toshiaki, Alexey S. Revenko, Justin Tibbitts, et al.. (2019). Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice. Blood Advances. 3(20). 3080–3091. 23 indexed citations

17.

Silasi‐Mansat, Robert, Ravi S. Keshari, Cristina Lupu, et al.. (2019). Inhibition of contact-mediated activation of factor XI protects baboons against S aureus–induced organ damage and death. Blood Advances. 3(4). 658–669. 57 indexed citations

18.

Wallisch, Michael, Erik I. Tucker, Christina U. Lorentz, et al.. (2017). The Anti-Factor XII Antibody AB052 Is Antithrombotic without Hemostatic Impairment in a Primate Model of Extracorporeal Membrane Oxygenation. Blood. 130. 236–236. 4 indexed citations

19.

Wood, David C., Leslie A. Pelc, Nicola Pozzi, et al.. (2014). WEDGE: an anticoagulant thrombin mutant produced by autoactivation. Journal of Thrombosis and Haemostasis. 13(1). 111–114. 5 indexed citations

20.

Rubin, Olivier, Julien Delobel, Michel Prudent, et al.. (2012). Red blood cell–derived microparticles isolated from blood units initiate and propagate thrombin generation. Transfusion. 53(8). 1744–1754. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact